Fructose in perspective by Richard D Feinman & Eugene J Fine
Fructose in perspective
Feinman and Fine
Feinman and Fine Nutrition & Metabolism 2013, 10:45
http://www.nutritionandmetabolism.com/content/10/1/45
Feinman and Fine Nutrition & Metabolism 2013, 10:45
http://www.nutritionandmetabolism.com/content/10/1/45REVIEW Open AccessFructose in perspective
Richard D Feinman1* and Eugene J Fine1,2Abstract
Whether dietary fructose (as sucrose or high fructose corn syrup) has unique effects separate from its role as
carbohydrate, or, in fact, whether it can be considered inherently harmful, even a toxin, has assumed prominence in
nutrition. Much of the popular and scientific media have already decided against fructose and calls for regulation
and taxation come from many quarters. There are conflicting data, however. Outcomes attributed to fructose —
obesity, high triglycerides and other features of metabolic syndrome — are not found in every experimental test
and may be more reliably caused by increased total carbohydrate. In this review, we try to put fructose in
perspective by looking at the basic metabolic reactions. We conclude that fructose is best understood as part of
carbohydrate metabolism. The pathways of fructose and glucose metabolism converge at the level of the triose-
phosphates and, therefore, any downstream effects also occur with glucose. In addition, a substantial part of
ingested fructose is turned to glucose. Regulation of fructose metabolism per se, is at the level of substrate
control — the lower Km of fructokinase compared to glucokinase will affect the population of triose-phosphates.
Generally deleterious effects of administering fructose alone suggest that fructose metabolism is normally
controlled in part by glucose. Because the mechanisms of fructose effects are largely those of a carbohydrate, one
has to ask what the proper control should be for experiments that compare fructose to glucose. In fact, there is a
large literature showing benefits in replacing total carbohydrate with other nutrients, usually fat, and such
experiments sensibly constitute the proper control for comparisons of the two sugars. In terms of public health, a
rush to judgement analogous to the fat-cholesterol-heart story, is likely to have unpredictable outcome and
unintended consequences. Popular opinion cannot be ignored in this problem and comparing fructose to ethanol,
for example, is without biochemical correlates. Also, nothing in the biochemistry suggests that sugar is a toxin.
Dietary carbohydrate restriction remains the best strategy for obesity, diabetes and metabolic syndrome. The
specific contribution of the removal of fructose or sucrose to this effect remains unknown.
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Fructose (as sucrose or high fructose corn syrup
(HFCS)) has become an obsession in nutrition. Painted
as uniquely harmful [1], even a toxin, in both popular
[2] and scientific publications [3-5], there are calls for
regulation and taxation from many quarters. While there
is little disagreement about the benefits of reducing
sugar as a means of restricting caloric intake or of redu-
cing total carbohydrates, especially for children, few
studies directly test the effect of fructose reduction. The
unique effects of adding fructose (compared to glucose)
are less clear-cut (e.g. [6]) and must be reconciled with
basic metabolic processes. In our opinion, the discussion* Correspondence: feinman@mac.com
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distribution, and reproduction in any mediumof fructose shows a lack of restraint that is reminiscent
of what is now recognized as a rush to judgment on
dietary fat and cholesterol. It seems worthwhile to step
back and put fructose in perspective.
From an evolutionary standpoint, fructose, like all car-
bohydrates, was a sign of good times. It is generally be-
lieved that the background availability of carbohydrates
and fructose in particular, was low and intermittent in
paleolithic times. Fluctuations in dietary scarcity and
abundance were likely much greater than they are now.
Selective advantage lay in dealing with the lean years,
metabolizing whatever low background fructose was
available, as well as being able to handle the high levels
of consumption that frequently attend sudden good
luck. It is likely that what might be considered over-
consumption today was part of our behavioral repertoireentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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as fat and glycogen, that might not be available in the
immediate future. It is important to remember that evo-
lution is value-free and being able to eat a lot at one sit-
ting might be beneficial in some circumstances. In
general, what is called pathology is a human perspective
and not a true biological concept; biological systems sur-
vive by adapting to different conditions.
In this review, we try to describe how human metabol-
ism deals with high fructose input. Eating beyond imme-
diate needs, for any macronutrient, predicts storage in
the form of fat or glycogen and high fructose input is as-
sociated with both. Glycogen synthesis, de novo lipogen-
esis (DNL) and TAG synthesis are, in fact, characteristic
of high fructose input. It is in the context of an intermit-
tent and highly reinforcing food source, not the context
of a poison, that fructose should be considered.
The metabolism of fructose is closely tied to that of
glucose (Reviews: [7-10]). In this communication, we try
to address the following questions: How can unique ef-
fects of fructose, increased TAG and insulin resistance,
when they are observed, be reconciled with the continu-
ity of glucose and fructose metabolic pathways? What
accounts for specific effects of fructose administered
parenterally? Insofar as fructose and glucose are tied to
similar pathways, what is the proper control for an
experiment in which one sugar is substituted for the
other?
Our conclusion is that fructose is best understood as
part of the general pathways of carbohydrate metabol-
ism. Any unique effects of fructose are mediated by in-
teractions with glucose as well as by a significant
conversion of fructose to glucose. The important differ-
ence in the processing of the two sugars lies in the early
steps, the much greater affinity of fructokinase com-
pared to glucokinase, that is, regulation is at the level of
substrate control, affecting the population of the triose-
phosphates. Because of their close connection, replacing
dietary fructose with glucose as a therapeutic measure is
expected to be variable, dependent on the particular
conditions and individual responses. Even those studies
that show unique effects tend to have large errors and
many cannot distinguish between the effects of added
fructose vs glucose. In addition, some experimental
studies, probably most, require fairly high levels of fruc-
tose. Replacing fructose with glucose is also expected to
be less effective in reducing risk factors than substitu-
tion of fat for any carbohydrate. Dietary carbohydrate
restriction remains the most effective, if under-utilized
strategy against obesity, diabetes and metabolic syn-
drome in trials of various duration and protocols
([11-18] and Additional file 1).
From a public health standpoint, the scarcity of
studies showing significant improvement of metabolicabnormalities by specific reduction in dietary sucrose
or fructose is of concern since that is being
recommended for the population at large. It might be
prudent to avoid another grand experiment on the
whole population — as the diet-heart paradigm has
been described — in the absence of data from even
small studies and without consideration of unintended
consequences.
General perspective on fructose metabolism
“Ay, in the catalogue ye go for men;
As hounds and greyhounds, mongrels, spaniels, curs,
Shoughs, water-rugs and demi-wolves, are clept
All by the name of dogs: the valued file
Distinguishes the swift, the slow, the subtle,
The housekeeper, the hunter, every one
According to the gift which bounteous nature
Hath in him closed”
— William Shakespeare, Macbeth
Fructose is a carbohydrate. It is processed by incorpor-
ation into carbohydrate metabolism. Specific effects that
are brought about by fructose elevation derive from an in-
crease in the intermediates of carbohydrate metabolism.
For humans, there is a background of dietary intake in
which glucose almost always exceeds fructose and where
fructose is rapidly cleared while glucose is maintained at
constant levels. Most important, a significant amount of
ingested fructose is converted to glucose (Figure 1).
Fructose and glucose metabolism converge at the level
of the triose-phosphates (Figure 1). The major concerns
in fructose metabolism — synthesis of glycerol-3-phos-
phate (glycerol-3-P) for triglyceride synthesis, generation
of acetyl-CoA for the TCA cycle and de novo lipogenesis
(DNL) — derive from these intermediates. The conun-
drum for understanding fructose metabolism is how a
carbon in the triose-phosphates knows whether it came
from fructose or glucose. The triose-phosphates are also
intermediates in gluconeogenesis; under normal condi-
tions, between 30 and 50% of ingested fructose is turned
to glucose [8] and high fructose also stimulates glycogen
production [19,20]. Finally, glucose is the major secreta-
gogue of insulin which controls glycogen metabolism,
triglyceride assembly and breakdown, and DNL. Taken
together, these considerations suggest some circumspec-
tion in the consideration of what, if anything, “added
fructose” might mean.
In such a complex system, experimental details be-
come important. In particular, the effect of adding fruc-
tose vs glucose to a diet whose background composition
is already high in carbohydrate is sensibly different from
one where there is low total carbohydrate. Specific
effects of fructose likely represent kinetic effects — more
rapid population of intermediates from fructose — but
these may also depend on individual conditions.
Figure 1 Overview of the major aspects of hepatic metabolism of glucose and fructose. Key points emphasized in the text: the two sugars
converge at the level of the triose-phosphates (dihydroxyacetone-phosphate (DHAP) and glyceraldehyde-3-P (Ga-3-P)). Conversion of fructose to
the triose-phosphates is unidirectional but fructose-1-phosphate is a positive effector of glucokinase and regulates glycogen synthesis by
activating the synthase and inhibiting phosphorylase. The last effect may be different between species. Light blue arrows show the path of
gluconeogenesis from fructose leading to glucose-6-P which, in turn, can produce glucose or be incorporated into glycogen.
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high Km of glucokinase, the effects of added glucose or
fructose will be indistinguishable. McDevitt, et al. [21],
for example, found the same level of DNL in obese and
lean women exposed to 50% overfeeding of glucose or
sucrose. At low sugar/low carbohydrate ingestion, the
output may be controlled by compounds that derive
from fructose but, in fact, it has been suggested that glu-
coneogenesis may be the primary effect [7]. Compari-
sons of low fructose and glucose are not well studied,
presumably because they are not considered to involve a
health risk.What is the appropriate control for a fructose-glucose
comparison?
Metabolism is value-free, that is, the response to
overconsumption of fructose may have been advanta-
geous for an organism with intermittent supply of carbo-
hydrate. The current discussion in nutrition, however, is
couched in terms of good and bad. A person with meta-
bolic syndrome may already have a poor response to the
widely studied (and recommended) 55% carbohydrate
that is considered standard [22,23] but that level is
slightly higher even than current consumption. Under
these conditions, any added fructose may be worse than
glucose but this is expected to be a minor perturbationin the effect of the high carbohydrate that has already
caused, e.g., high triglycerides.
To some extent, the question is a logical one. Numer-
ous studies have demonstrated the benefits of restriction
of carbohydrates in general (Supplement). The question,
then, is what is the appropriate control for those experi-
ments in which different carbohydrates are compared. If
there is a null hypothesis, it is that the effects of fructose
are primarily due to its role as a carbohydrate. The appro-
priate comparison, then, would be experiments in which
carbohydrates across the board are substituted with an-
other macronutrient, generally fat. We will provide an ex-
ample of the effects of studies in the lab of Jeff Volek that
can be compared to fructose studies [12,14,24].
Hepatic uptake of glucose and fructose
The liver is not the only organ that metabolizes fructose
but hepatic metabolism accounts for at least half of the
total and represents the focus of most concern. As a
kind of command center in metabolism, the liver distrib-
utes energy to other cells in the form of glucose, lactate
and triglycerides although other tissues, intestines, kid-
ney and muscle, can also process fructose directly. In the
case of the kidney, lactate and glucose from fructose
may also be exported.
Glucokinase, the hepatic hexokinase, has a high Km —
in the range of normal blood glucose — so that liver and
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fluctuate according to high blood glucose and other acute
changes, for example, following starvation (Figure 1). Un-
like the hexokinases of peripheral tissues, glucokinase is
not subject to product inhibition by glucose-6-P but is
subject to other regulation including an increase in activity
in response to even small amounts of fructose.
Fructose is a poor substrate for glucokinase and most
enters metabolism via the fructokinase-catalyzed reac-
tion whose product is fructose-1-P). The low Km of
fructokinase (0.5 mM) means that plasma fructose is
rapidly cleared. Fructokinase exists in two isoforms, A
and C. The latter, expressed primarily in the liver, has
high affinity for fructose and leads to rapid incorporation
and depletion of ATP at least as measured in mice.
Fructokinase A has wider tissue distribution and its
lower affinity for fructose appears to reduce the amount
of fructose for metabolism in the liver [25]. The appar-
ent heterotropic positive cooperativity of glucokinase
turns out to be due to activation by fructose-1-P
(Figure 1).
Regulation of hepatic fructose processing
Phosphorylation of fructose is regulated at the substrate
level (low Km) and in transcription (expression is regu-
lated by ChREBP (carbohydrate response element bind-
ing protein) [26]). There is no allosteric or hormonal
control in the reaction itself and fructose is usually said
to bypass phosphofructokinase-1 (PFK-1) which regulates
glucose metabolism. In addition, the lysis step catalyzed
by aldolase-B differs from the aldolase in glycolysis, pro-
ducing dihydroxyacetone phosphate (DHAP) and glyceral-
dehyde. The latter, unlike the products of aldolase, must
be phosphorylated. Little attention is usually paid to the
kinase reaction but it points to the role of the liver as a
direct consumer of fructose. Aldolase B reaction is revers-
ible but the glyceraldehyde kinase is not: there is no
“fructoneogenesis”.
Although the fructokinase reaction is not subject to
allosteric regulation, the PFK-1 step itself exerts control
on the down-stream metabolism of fructose. Under con-
ditions of high energy charge and high fructose intake
(the focus of current interest), PFK-1 is down regulated
by ATP, and by a long feedback loop from citrate. Simi-
larly, fructose-1, 6-bisphosphatase is stimulated by the
high energy charge. The overall effect is increased gluco-
neogenesis from the triose-phosphates, (light blue path-
way in Figure 1), net conversion of fructose to glucose
and, as described below, a high potential for glycogen
synthesis.
Regulation of uptake and phosphorylation
Fructose-1-P exerts positive allosteric control on gluco-
kinase. It is now understood that the high Km ofglucokinase, and its apparent allosteric properties, are
due to binding of an inhibitory glucokinase-regulatory
protein (RP; Figure 2) that reduces its affinity for sub-
strate. Fructose-1-phosphate relieves inhibition by bind-
ing to RP thereby stabilizing the dissociated proteins.
Inhibition is a consequence of translocation of the
glucokinase-RP complex to the nucleus [27]. Dissoci-
ation of RP and transport from the nucleus is enhanced
by postprandial glucose and insulin [28]. Additional
regulation is provided by fructose-6-P from glycolysis
which acts as a feedback inhibitor of glucokinase, chan-
ging the affinity for RP, re-establishing binding and
returning the enzyme to the nucleus, thereby creating an
apparent higher Km state.
Fructose might be thought of as a metabolic signal for
affluence, calling for additional glucose via relief of in-
hibition of glucokinase. This response, an apparent
equalizing of added fructose and glucose, may be of gen-
eral importance. Administration of fructose alone may
be a distinctly abnormal state for the human liver which
evolved in an environment where the sugars were always
presented together. Thus fructose, directly and indirectly
increases the effective level of glycolytic intermediates.
Hepatic carbohydrate metabolisms responds to lower
plasma levels of fructose than of glucose but the com-
bination of fructose and glucose is expected to be stron-
ger than fructose alone. A further prediction is that
under conditions of high plasma glucose, conditions
where the Km of glucokinase is exceeded, differences be-
tween the two sugars should cancel out. Again, DNL,
under conditions of overfeeding, conform to this predic-
tion [21].
Gluconeogenesis
A large fraction of ingested fructose is converted to glu-
cose [8]. Delarue, et al. [29] used deuterated glucose and
naturally-occurring 13C-labelled fructose. After a 6 hour
period, addition of 0.5 g/kg fructose led to the appear-
ance of 0.27 g/kg of labeled glucose while, for ingestion
of 1 g/kg fructose, 0.59 g/kg of glucose was synthesized.
These values represent 56% and 59% of the fructose
loads. Similar results, reviewed by Sun [8], have been
found by others. Gluconeogenesis from fructose is
generally assumed to proceed as shown by the light blue
arrows in Figure 1 [8]. It is not excluded that gluconeo-
genesis goes through pyruvate although the cycle,
PEP→ pyruvate→ PEP is more energetically unfavorable
than the reverse-aldolase reaction. The process will also
be sensitive to the varying energy charge and presence
of other macronutrients.
Glycogen
As expected for a response to times of plenty, high fruc-
tose enhances glycogen storage (Figure 1) either directly
Figure 2 Control of glucokinase. Binding of glucokinase-regulatory protein (RP) reduces the activity of glucokinase (GK). Fructose-1-P
relieves the inhibition by stabilizing the dissociated RP, while F-6-P furthers inhibition by stabilizing the complex. Not shown in the figure: the
GK-RP complex is transported to the nucleus [27]. Dissociation leads to transport from the nucleus.
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effects of glucose and fructose were studied in primary
cultures of hepatocytes from rats deprived of food for
24 hours. Parniak and Kalant [19] measured the incorpor-
ation into glycogen of [14C]-glucose in the presence of cold
fructose and incorporation of [14C]-fructose in the pres-
ence of cold glucose. The results, shown in Figure 3 indi-
cate that label from either sugar (in the form of glucose) is
incorporated into glycogen in a dose-dependent manner.
Each sugar enhanced the incorporation of the other (red
symbols) and, in both cases, high insulin (heavy line) in-
creased the total yield compared to its absence (gray line).
Fructose leads to greater incorporation presumably due,Figure 3 Incorporation of labeled glucose or fructose as a function of
other (cold) sugar. Incorporation of labeled sugar in the absence of the o
the other (unlabeled) sugar is added there is a shift in the incorporation as
enhanced upon addition of insulin (heavy black lines). Figure redrawn fromagain, to relative higher uptake and phosphorylation but
most notable is the similarity of the patterns and the extent
of conversion of fructose to glucose.
This stimulating effect of fructose was demonstrated in
humans by Petersen, et al. [20] in elegant experiments
measuring the rates of hepatic glycogen synthesis in vivo
using 13C-NMR under euglycemic hyperinsulinemic con-
ditions. Infusions of 13C-labeled glucose in the presence
or absence of fructose were followed by a cold chase to
determine rates of synthesis and breakdown. In distinction
to the results with hepatocytes, increased flux was due to
the glycogen synthase reaction (2.5-fold) rather than an
inhibition of phosphorylase activity (Figure 1).concentration of the labeled sugar and effect of presence of
ther is shown by the blue symbol and the unbroken gray line. When
shown by the red symbol and the gray broken line). All the effects are
Parniak & Kalant [19].
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High fructose is frequently described as causing insulin
resistance and metabolic syndrome (MetS) and there are
several observations supporting the idea (e.g., [23]). Most
such experiments, however, are done under conditions of
high total carbohydrate where, again, separate effects of
the sugars and their interactions are inadequately
addressed. Also, not all tests show a clear fructose effect.
Most recently, Lecoultre, et al. [30] demonstrated reduc-
tion in hepatic insulin sensitivity by overfeeding fructose.
However, as seen in Figure 4, there was great variation
and overfeeding glucose had a similar effect.
An important question is the operational definition of
insulin resistance. Dirlewanger, et al. [31] measured the
insulin required to maintain an 8 mM glucose concen-
tration during a hyperglycemic clamp with or without
the addition of 16.7 μM/kg/min fructose. The fructose
addition caused an increase of insulin demand by 2.3-
fold and doubled glycogen synthesis. Using radio-labeled
glucose, they showed that there was no effect of fructose
on endogenous glucose production or total output com-
pared to control. When measurements were made under
a hyperinsulinemic hyperglycemic clamp protocol, fruc-
tose addition caused an 11.1 μM/kg/min increase in
total glucose output, increased net endogenous glucose
production and increased glucose cycling. The results
were described as hepatic insulin resistance, that is,
more insulin was needed to maintain the level of blood
glucose in the presence of fructose and, conversely, high
insulin did not repress production of glucose.Figure 4 Hepatic insulin sensitivity (100/(glucose production ×
fasting insulin)). Male subjects consumed weight maintenance
diets for 6–7 days and then the indicated amount of sugar was
added to the same diet. Data from reference [30].Although the results conformed to an operational def-
inition of insulin resistance, Dirlewanger, et al. [31] pro-
vided an explanation of the results which seems like a
normal response to the experimental conditions and
which would be consistent with the mechanism in
Figure 1: the effective hepatic glucose concentration is
very much higher in the fructose group due to the ex-
tensive gluconeogenesis. This will lead to enhanced total
glucose output despite the high insulin concentration, an
insulin concentration that was able to repress output in
the glucose-alone controls. At the same time, fructose-1-P,
by causing an increased glucokinase activity, would lead to
enhanced re-uptake of glucose and increased glucose cyc-
ling. Thus, apparent insulin resistance is the effect of
higher levels of glucose intermediates in a fructose-
stimulated cell and does not represent any basic detrimen-
tal change in hepatic physiology.
The concept of insulin sensitivity or resistance is thus
strongly dependent on the method of measurement and
the operational definition. Insulin resistance may be a
characteristic of type 2 diabetes and the sine qua non of
metabolic syndrome but, depending on what is mea-
sured, need not be associated with maladaptive re-
sponses to food or other stimulation and my represent
productive adaptation to different conditions.
Again looking at the influence of total dietary carbohy-
drate as a control, it is known that carbohydrate restric-
tion across the board will improve all of the features of
MetS. It was suggested, in fact, that the response of all
of the individual markers of MetS to reduced carbohy-
drate might serve as an operational definition [13], given
that there is some question as to whether the syndrome
even exists [32]. This is important in that it is reasonable
that at least some part of insulin resistance is down-
regulation of response due to chronic high insulin as in
many hormonal systems. Reduction in glucose, rather
than fructose, will reduce this high insulin.
A critical prospective test was carried out by Volek
and coworkers who assigned 40 overweight men and
women with the atherogenic dyslipidemia characteristic
of MetS (high TAG, low HDL-C, high concentration of
small dense LDL) to a very low carbohydrate ketogenic
diet (VLCKD) in [12,14,24]. An isocaloric fat-restricted
diet served as control. Compared to these controls, the
VLCKD group showed greater improvement in body
mass, in glycemic control, and in many of the features
of MetS: TAG, HDL-C, apo B, apo A-1 and LDL
particle size distribution as well as a greater anti-
inflammatory effect. The extent to which these effects
of carbohydrate restriction were specifically due to
removing fructose or sucrose is unknown but the mag-
nitude of the effect (although in the direction of im-
provement) are generally larger than those seen in
glucose-fructose comparisons.
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hydrates is effective in reducing the features of metabolic
syndrome. Until there is evidence that it is specifically
sugar that was removed, logic dictates that carbohydrate
restriction is the preferred approach.
Triglycerides
Carbohydrate-induced hypertriglyceridemia and its flip-
side, reduction in triglycerides by dietary carbohydrate
restriction, are well established phenomena. The effect is
generally attributed to the increased flux of insulin
which inhibits lipolysis and the reduction in glycerol-3-P
to provide substrate for synthesis. It is unknown whether
and to what extent there is a unique effect of fructose
but several papers have indicated a high potential for
fructose to increase plasma TAG compared to the effect
of glucose [22,33-35]. There are, however, conflicting re-
ports [11] and, again, most of the recent studies have
been done against a baseline of high total carbohydrate
or unusually high fructose, or both, meaning that base-
line may already be very high.
Chong, et al. showed that, under acute postprandial
conditions, little activity from radio-labeled fructose
showed up in the fatty acid portion of TAG, that is, fatty
acids are primarily from endogenous fat [35]. DNL is
relatively small for either glucose or fructose. On the
other hand, a maor part (38%) of the glycerol comes
from labeled fructose, consistent with the idea that the
main effect of fructose is to more rapidly, or to a greater
extent, populate the triose-phosphates.
Figure 5 shows typical results from Stanhope, et al.
[34] who measured the relative effects of consumptionFigure 5 24-hour circulating triacylglycerol before (black) or after 2, 8
fructose-sweetened beverages (red) providing 25% of energy. Superpof glucose- or fructose-sweetened beverages in over-
weight and obese subjects. The sugar-sweetened drinks
provided 25% of energy requirements for 10 weeks. The
figure shows superimposed fructose and glucose curves
from reference [34]. On average, the fructose curve has
larger postprandial excursions but the difference in the
curves is of the order of 10% which, in combination with
the very large error bars makes the data questionable.
The error bars in the figure, in fact, represent the stand-
ard error of the mean (SEM). SEM can provide a statis-
tical measure of the difference in the populations, but in
terms of presentation of data, it does not communicate
very well a sense of the true variability of the individual
data. The standard deviation (SD), a better indicator of
the true variation, is obtained by multiplying by √n
which, in this case, is 3.7 for glucose and 4.1 for fructose.
With such large variation, a couple of outliers would
change the character of the curve. In other words,
whereas there is a unique effect of fructose, it is not
large and appears to be highly variable.
Similarly, Teff, et al. [22] found significantly higher
TAG in a group that consumed 30% of their total energy
input in fructose-sweetened beverages as compared to a
group who ingested glucose-sweetened beverages. This
level of consumption is fairly high compared to the aver-
age in the United States (about 10%) but, of greater sig-
nificance is, once again, the large individual variation.
Dividing subjects in both groups into sub-populations
on the basis of insulin sensitivity showed that, in fact,
differences due to insulin sensitivity within each sugar
were as great as the differences between the two sugars.
As shown 0in Figure 6, insulin-resistant subjects in theand 10 weeks of consuming glucose-sweetened (blue) or
osition of Figures 2A and 2B, redrawn from Stanhope, et al. [34].
Figure 7 Effect of diet on postprandial lipemic responses in
subjects with atherogenic dyslipidemia. Absolute TAG values in
subjects who consumed a very low carbohydrate ketogenic diet
(VLCKD) or a low-fat diet (LF) for 12 weeks. Redrawn from Volek,
et al. [24].
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jects in the fructose arm. Because of the importance of
insulin resistance, it is reasonable to think that insulin
will be the true variable of interest.
The association between levels of dietary carbohydrate
and plasma TAG may be the single most predictable effect
of nutrients on lipid metabolism (reviews: [11,13,14]).
That increases in plasma TAG are not always seen in high
fructose feeding [36] suggests that it is not the major, or at
least, not the only player. The proper control, again, is
substitution of total carbohydrate with something else,
sensibly fat. Although no such explicit comparison has
been done, replacing total carbohydrate with fat always
shows much greater changes than experiments in which
sugars are exchanged. For example, Volek, et al. [24] com-
pared two hypocaloric diets (~1,500 kcal): a carbohydrate-
restricted diet (%carbohydrate: fat:protein = 12:59:28) and
a low-fat diet (LFD) (56:24:20) in 40 subjects with athero-
genic dyslipidemia (high triglycerides, low HDL, high con-
centration of small dense LDL).
Figure 7 from Volek, et al. is representative. Changes
in TAG from replacing total carbohydrate are larger and
more reliable than studies in which glucose replaces
fructose. Hollenbeck [36] reviewed studies through 1993
on the effect of fructose on lipid metabolism. Of 18 rele-
vant studies, she considered that only 8 met the criteria
of 1) sufficient dietary and experimental control, 2)
glucose or starch for comparison; and 3) had limited
heterogeneity present in the study population. Of these
8, half showed no change in plasma TAG while one
found no change in a normal group but an increase inFigure 6 Comparative effects of fructose-sweetened (red) and
glucose-sweetened beverages (blue). Data from Teff, et al. [5]
were merged. Insulin-sensitive (−□-) and insulin-resistant (−○-)
sub-groups were separately analyzed from the original populations.subjects with hypertriglyceridemia, and one study simi-
larly found no change in the normal population with in-
creases in subjects with hyperinsulinemia. Only two
studies found increases in TAG.
De novo lipogenesis
De novo lipogenesis (DNL), is an important feature of
the state of high energy charge and/or high carbohydrate.
Differential effects of glucose and fructose (reviewed in
reference [37]) follow the pattern described here. For ex-
ample, Hudgins, et al. [38] measured percent increase in
palmitate in VLDL-TAG. Consistent with the idea that
fructose ingestion may change total availability of sugars
in the liver, they found that fructose has a much greater
effect than glucose when administered alone; an oral
glucose tolerance test (OGTT) had little effect. How-
ever, adding glucose to a dose of fructose increased
DNL, and as total carbohydrate becomes high, exceed-
ing the Km of glucokinase, there is little difference be-
tween sugars (Figure 8), absolute changes, however, are
small and, again, there is great variability.
One of the features of Volek’s study described above
was that, despite a 3-fold higher intake of dietary satu-
rated fat during the VLCKD, saturated fatty acids in
TAG and cholesteryl ester were significantly decreased
compared to low-fat controls. That this was due to a de-
crease in DNL was shown by a corresponding reduction
in palmitoleic acid (16:1n-7), the product of the
desaturase. Palmitoleic acid is present in only low
Figure 8 Effect of sugar on percentage of palmitate (16:0) in VLDL TG before and after OGTT (glucose, 75 g; average, 0.8 g/kg) and
indicated levels of fructose (F) and glucose (G). Redrawn from reference [38].
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indication of DNL.
Effects of pure fructose
Because of its limited effect on insulin secretion, it was
originally thought that fructose might be a desirable sugar
for people with diabetes. However, this proved to be not
only ineffective but led to the risk of lactic acidosis. Simi-
lar effects of pure fructose are observed in parenteral nu-
trition [39] or administering fructose during exercise [40].
This response has traditionally been explained as a kinetic
effect due to the rapid phosphorylation of fructose and a
depletion of ATP. One of the consequences is increased
glycolysis and increased lactic acid production. Under
conditions where both fructose and glucose are available,
there is somewhat greater lactic acid production from
higher fructose although there is no threat of acidosis and
lactic acid is one of the ways that fructose supplies energy
to extrahepatic cells. While speculative, a reasonable de-
duction is that hepatic metabolism has evolved so as to re-
quire glucose for fructose metabolism. The cytosol is
much more oxidizing than the mitochondrion and conver-
sion of DHAP to glycerol-3-P requires NADH. At low
NADH, glyceraldehyde-3-P will be oxidized to provide
ATP and NADH, resulting in conversion to pyruvate and
to lactate production. In addition, there are reported di-
gestive effects of fructose alone which indicate the involve-
ment of problems in absorption. It may be that results
with fructose alone cannot be compared to results where
both sugars are present and such interventions may not
be a good model for human consumption which almost
never includes pure fructose.
Effect of energy charge
It is widely reported that fructose depletes ATP due to the
fructokinase reaction [1] although this has generally beenobserved in isolated hepatocyte cultures and with addition
of pure fructose. The major focus of current interest are
studies done under conditions of high energy charge and
the reactions characteristic of fructose — glycogen and tri-
glyceride formation — require ATP. Veech, et al. showed
that high ATP accompanied a high sucrose diet [41].
Oddly, Abdelmalek, et al. [42] reported that fructose
lowered hepatic ATP as measured by 31P-nuclear mag-
netic resonance (NMR) but their data did not support that
deduction. The effects on ATP may be dependent on par-
ticular conditions. The effects of different conditions of
substrate source and particularly exercise are beyond the
scope of this review but there is, again, a good deal of vari-
ability as seen even in the effects on rates of oxidation of
different sugars (Review: [8]). As noted above, the pres-
ence of fructose tends to increase the levels of plasma lac-
tate but, generally, differences between dietary glucose vs.
fructose + glucose tends to become smaller and, as in
other conditions, fructose alone is not desirable [43].Conclusions
There are clearly specific effects of fructose but we
emphasize that these must be rationalized in the face of
the continuum between fructose and glucose metabolism.
Control of fructose metabolism is primarily at the level of
substrate regulation, the more favorable Km of fructokinase
compared to glucokinase. Because downstream metabol-
ism of fructose from the triose-phosphates is the same as
that for glucose, there is an expectation that there will be
variability among studies. This expectation is borne out
and even those that have clear-cut outcomes, show signifi-
cant statistical error.
Finally, nobody is suggesting that continued high con-
sumption of sugar is good but there there is a logical
problem and a practical problem. Logically, you cannot
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effect of carbohydrates. It doesn’t make sense.
Removing sugar without replacement is obviously
good for weight loss but practically speaking, if we want
to reduce sugar consumption isocalorically, we must
consider whether to replace sugar with starch or with
another nutrient, usually fat. There are numerous studies
showing the benefit of the latter approach but few dem-
onstrating the value of the former. Showing that fructose
is worse than glucose under some conditions is not the
same thing as showing that specifically removing fruc-
tose is beneficial. Until these comparisons are made, it
seems like a good idea to keep some perspective.
While studies with combinations of fructose and glu-
cose are consistent with a general effect of carbohydrate,
fructose alone appears to have aberrant behavior and
one might speculate that the system evolved to deal with
the two sugars together, consistent with the general ab-
sence of pure fructose outside of experimental trials.
From the perspective of ideas in the popular media,
however, there is little relation between fructose metab-
olism and ethanol metabolism and it is unreasonable to
refer to fructose as a toxin.
Discussion
The strongest argument for caution in a strategy of spe-
cifically removing fructose (as sucrose or HFCS) from
the food supply is the absence of significant prospective
trials. In terms of basic metabolism, fructose is incorpo-
rated into general carbohydrate metabolism which may
have specifically evolved to deal with the sudden appear-
ance of desirable food. Persistence in a state of over-
consumption has serious consequences and there is a
clear benefits in restricting sugar, especially for children.
However, suggesting that fructose is somehow a foreign
substance is not consistent with the science and, there-
fore, should not be the basis of policy. There is a con-
tinuum from scientific studies to popular media that
suggests a circumspect approach is unlikely and, in
our opinion, there is a clear sense of a rush to judgement
on sugar, entirely analogous to that in the diet-heart-
cholesterol phenomenon. Perhaps the most important
similarity is that both official agencies and individual
doctors and researchers are recommending, even de-
manding, reduction in sugar, despite the absence of any
experimental test of the idea. The message to reduce
fat and cholesterol was, similarly, made before any test
of what the outcomes might be. Given increasing evi-
dence of risk from high total carbohydrate intake, the
likelihood of unintended consequences from reducing
fructose alone (starch replacing sugar) is strong.
Emphasizing fructose outside of general carbohydrate
metabolism has the serious limitation of substantially
ignoring the hormonal effects of glucose the majorsecretagogue of insulin. In people with type 2 diabetes,
removing starch is more beneficial than removing sugar
[44] and effective treatment has been demonstrated in
several studies from Nuttall and Gannon where the con-
trolling variable is reduction of what the authors call
bioavailable glucose [17,18,45]. In this area, at least, it
would be good to proceed carefully.
A virtue of the current emphasis on the dangers of
fructose is the appeal to an analysis based on basic me-
tabolism [3,4]. The points made in the current review
should be included in that analysis.
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